Global Gastrointestinal (GI) Stent Market Size, Share & Trends Report Segmented by Product Type (Biliary, Colonic, Duodenal, Esophageal, Pancreatic), Application (GI Cancer, Biliary Disease, Colorectal Cancer), Material (Plastic, Metal), End-user Analysis & Regional Forecast to 2030

The global gastrointestinal stent market is expected to grow at a CAGR of ~6% during the forecast period. Rising incidence of gastrointestinal cancers and digestive tract obstructions coupled with the increasing preference for minimally invasive procedures, advancements in stent design and materials, and a rising geriatric population prone to GI disorders, are some of the key driving factors supporting the market growth. To learn more about the research report, download a sample report.

Overview

Gastrointestinal (GI) stents are specialized medical devices used to open and maintain the patency of obstructed or narrowed regions within the GI tract. These stents are typically inserted through minimally invasive endoscopic or radiological procedures and are commonly used to treat obstructions caused by malignancies, strictures, or other GI disorders. GI stents play a crucial role in restoring normal digestive function, reducing symptoms such as pain, nausea, or vomiting, and improving the quality of life, particularly for patients with advanced GI cancers or benign strictures. Some common types of gastrointestinal stents include esophageal, biliary, duodenal, colonic, pancreatic, and biodegradable and drug-eluting stents. Overall, gastrointestinal stents are essential interventional tools that offer significant clinical benefits by enabling non-surgical relief from GI obstructions and supporting effective palliative care in cancer patients.

To learn more about this report, download the PDF brochure

Rising GI disorders and demand for minimally invasive solutions fuel the market growth

The increasing global burden of GI cancers and non-malignant GI disorders significantly drives the gastrointestinal stent market. According to an article published in the NIH, GI cancers accounted for 4.8 million new cases and 3.4 million deaths in 2020, making them among the leading causes of cancer-related mortality worldwide. Also, according to the WHO, colorectal cancer alone was the third most commonly diagnosed cancer globally.

Further, non-cancerous GI conditions like gastroesophageal reflux disease (GERD), peptic ulcers, strictures, inflammatory bowel disease (IBD), and chronic pancreatitis are also on the rise. Factors contributing to the increasing prevalence of these conditions include sedentary lifestyles, poor dietary habits, and aging populations, among others. Additionally, the increasing incidences of both malignant and benign GI conditions are contributing to greater demand for therapeutic solutions like stents, which help restore lumen patency, reduce obstruction-related symptoms, and improve patient outcomes in both curative and palliative care settings.

Simultaneously, there is a growing shift toward minimally invasive procedures, such as esophageal stenting, driven by patients' preferences for faster recovery and fewer complications. Together, the rising prevalence of GI diseases and the increasing demand for less invasive treatment options are key factors propelling the adoption and expansion of the gastrointestinal stent market.

To learn more about this report, download the PDF brochure

Innovations in GI stents are advancing minimally invasive treatment options

The development of biodegradable and drug-eluting gastrointestinal (GI) stents marks a major step forward in endoscopic treatment for GI disorders. Traditional metal or plastic stents have been used to maintain patency in obstructed GI tracts; however, these materials often require secondary removal procedures and pose risks of infection, migration, and tissue injury. Biodegradable stents, composed of materials that naturally dissolve within the body over time, eliminate the need for stent retrieval, thereby reducing the risk of complications and improving patient comfort, especially in benign strictures which require temporary support.

Simultaneously, drug-eluting stents, which release therapeutic agents locally at the site of obstruction or stricture, offer targeted treatment, minimizing systemic side effects and improving clinical outcomes, particularly in cases involving malignancies, strictures, or inflammation. Together, these innovations enhance the therapeutic efficacy of stents, reduce hospital stays, and also align with the broader healthcare goals of minimally invasive intervention that improves quality of life for patients.

Competitive Landscape Analysis

The global gastrointestinal stent market comprises of several well-established and emerging players, including Boston Scientific Corporation; Cook Medical Inc.; Olympus Corporation; CONMED Corporation; Medtronic plc; ELLA-CS, s.r.o.; Becton, Dickinson and Company; Merit Medical Systems, Inc.; Hobbs Medical, Inc.; and W. L. Gore & Associates, Inc.; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.

Report Scope

Growth Rate

Report Metric	Details
Base Year Considered	2024
Historical Data	2023 - 2024
Forecast Period	2025 - 2030
~6%
Market Drivers	Rising incidence of GI cancers and obstructions Growing geriatric population more prone to GI disorders Increasing preference for minimally invasive procedures Growing awareness and early diagnosis of GI disorders Advancements in stent design and material
Attractive Opportunities	Rising demand for palliative care in cancer management Development of biodegradable and drug-eluting stents Expansion in emerging markets with rising healthcare infrastructure
Segment Scope	Product Type, Application, Material, and End-user
Regional Scope	North America (US & Canada) Europe (UK, Germany, France, Italy, Spain, Rest of Europe) Asia Pacific (China, India, Japan, Rest of Asia Pacific) Latin America Middle East & Africa
Key Companies Mapped	Boston Scientific Corporation; Cook Medical Inc.; Olympus Corporation; CONMED Corporation; Medtronic plc; ELLA-CS, s.r.o.; Becton, Dickinson and Company; Merit Medical Systems, Inc.; Hobbs Medical, Inc.; and W. L. Gore & Associates, Inc.; among others
Report Highlights	Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis

������

Global Gastrointestinal Stent Market Segmentation

This report by Medi-Tech Insights provides the������size of the global gastrointestinal stent market at the������regional- and country-level from 2023 to 2030. The report further segments the market based on product type, application, material, and end-user.

Market Size & Forecast (2023-2030), By Product Type, USD Million

"list-style-type: none">

• Biliary Stents
• Colonic Stents
• Duodenal Stents
• Esophageal Stents
• Pancreatic Stents

Market Size & Forecast (2023-2030), By Application, USD Million

• • Gastrointestinal Cancer
  • Biliary Disease
  • Colorectal Cancer
  • Stomach Cancer
  • Others

Market Size & Forecast (2023-2030), By Material, USD Million

• • Plastic
  • Metal
  • Others

Market Size & Forecast (2023-2030), By End-user, USD Million

• • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Others

Market Size & Forecast (2023-2030), By Region, USD Million

• North America
  • US
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Rest of Asia Pacific
• Latin America
• Middle East & Africa

Key Strategic Questions Addressed

• What is the market size & forecast of the gastrointestinal stent market?
• What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the gastrointestinal stent market?
• What are the key trends defining the market?
• What are the major factors impacting the market?
• What are the opportunities prevailing in the market?
• Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
• Who are the major players operating in the market?
• What are the key strategies adopted by players?

Related Reports

Gastrointestinal Endoscopic Devices Market Size, Share, Trends & Growth Analysis 2025 to 2030
Global Gastrointestinal Devices Market Size & Trends Report Segmented by Product Type (GI endoscopes, Laparoscopes, Biopsy Devices, ERCP), Application (Diagnostic, Therapeutic), End-user (Hospitals, Diagnostic Centers) & Regional Forecast to 2030
Gastrointestinal Devices MedTech Market - Global Industry Analysis, Size, Share, Growth and Forecast 2025 to 2030